Seretide 250 Evohaler

国家: 英国

语言: 英文

来源: MHRA (Medicines & Healthcare Products Regulatory Agency)

有效成分:

Fluticasone propionate; Salmeterol xinafoate

可用日期:

DE Pharmaceuticals

ATC代码:

R03AK06

INN（国际名称）:

Fluticasone propionate; Salmeterol xinafoate

剂量:

250microgram/1dose ; 25microgram/1dose

药物剂型:

Pressurised inhalation

给药途径:

Inhalation

类:

No Controlled Drug Status

处方类型:

Caution - AMP level prescribing advised

產品總結:

BNF: 03020000

资料单张

SERETIDE 250 EVOHALER
(SALMETEROL XINAFOATE/FLUTICASONE PROPIONATE)
PATIENT INFORMATION LEAFLET
This leaflet tells you about Seretide 250 Evohaler but will be
referred to
as Seretide throughout this leaflet. Seretide Evohaler is also
available in
other strengths.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their symptoms and signs of illness
are
the same as yours.
If you get any side effects talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See
section 4.
WHAT IS IN THIS LEAFLET:
1.
What Seretide is and what it is used for
2.
What you need to know before you use Seretide
3.
How to use Seretide
4.
Possible side effects
5.
How to store Seretide
6.
Contents of the pack and other information 1.
WHAT SERETIDE IS AND WHAT IT IS USED FOR
Seretide contains two medicines, salmeterol and fluticasone
propionate:
•
Salmeterol is a long-acting bronchodilator. Bronchodilators help the
airways in the lungs to stay open. This makes it easier for air to get
in
and out. The effects last for at least 12 hours.
•
Fluticasone propionate is a corticosteroid which reduces swelling and
irritation in the lungs.
The doctor has prescribed this medicine to help prevent breathing
problems such as asthma.
You must use Seretide every day as directed by your doctor. This will
make sure that it works properly in controlling your asthma.
SERETIDE HELPS TO STOP BREATHLESSNESS AND WHEEZINESS COMING ON.
HOWEVER SERETIDE SHOULD NOT BE USED TO RELIEVE A SUDDEN ATTACK OF
BREATHLESSNESS OR WHEEZING. IF THIS HAPPENS YOU NEED TO USE A FAST-
ACTING ‘RELIEVER’ (‘RESCUE’) INHALER, SUCH AS SALBUTAMOL. YOU
SHOULD
ALWAYS HAVE YOUR FAST-ACTING ‘RESCUE’ INHALER WITH YOU. 2.
WHAT YOU NEED TO KNOW BEFORE

产品特点

OBJECT 1
SERETIDE 250 EVOHALER
Summary of Product Characteristics Updated 04-Jun-2019 |
GlaxoSmithKline UK
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Seretide Evohaler 25 microgram/50 microgram per metered dose
pressurised inhalation, suspension.
Seretide Evohaler 25 microgram/125 microgram per metered dose
pressurised inhalation, suspension.
Seretide Evohaler 25 microgram/250 microgram per metered dose
pressurised inhalation, suspension.
2. Qualitative and quantitative composition
Each metered dose (ex valve) contains:
25 micrograms of salmeterol (as salmeterol xinafoate) and 50, 125 or
250 micrograms of fluticasone
propionate. This is equivalent to a delivered dose (ex actuator) of 21
micrograms of salmeterol and 44, 110 or
220 micrograms of fluticasone propionate.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Pressurised inhalation, suspension.
The canister contains a white to off white suspension.
The canisters are fitted into purple p